231 related articles for article (PubMed ID: 28301315)
1. Time and age dependent decrease of NT-proBNP after septal myectomy in hypertrophic obstructive cardiomyopathy.
Cui H; Wu X; Wang S; Tang B; Zhu C; Chen H; Zhou X; Wu R; Yu Q; Huang X
Clin Chem Lab Med; 2017 Aug; 55(10):1614-1620. PubMed ID: 28301315
[TBL] [Abstract][Full Text] [Related]
2. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
3. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
[TBL] [Abstract][Full Text] [Related]
4. Preoperative NT-proBNP Predicts Midterm Outcome After Septal Myectomy.
Song C; Wang S; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
J Am Heart Assoc; 2019 Feb; 8(4):e011075. PubMed ID: 30760079
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
[TBL] [Abstract][Full Text] [Related]
6. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
[TBL] [Abstract][Full Text] [Related]
8. Changes in left atrial function, left ventricle remodeling, and fibrosis after septal myectomy for obstructive hypertrophic cardiomyopathy.
Tang B; Song Y; Yang Q; Cui H; Ji K; Zhao S; Wang S
J Thorac Cardiovasc Surg; 2022 May; 163(5):1828-1834.e4. PubMed ID: 32778464
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.
Efthimiadis GK; Hitoglou-Makedou A; Giannakoulas G; Mitakidou A; Karamitsos T; Karvounis H; Mochlas S; Styliadis I; Stefanidis H; Parcharidis G; Louridas G
Heart Vessels; 2007 Sep; 22(5):322-7. PubMed ID: 17879024
[TBL] [Abstract][Full Text] [Related]
10. Determinants of elevated NT-proBNP levels in patients with hypertrophic cardiomyopathy: an echocardiographic study.
Kahveci G; Bayrak F; Mutlu B; Basaran Y
Heart Lung Circ; 2009 Aug; 18(4):266-70. PubMed ID: 19157978
[TBL] [Abstract][Full Text] [Related]
11. Preoperative left ventricular longitudinal strain predicts outcome of septal myectomy for obstructive hypertrophic cardiomyopathy.
Cui H; Schaff HV; Nishimura RA; Geske JB; Dearani JA; Newman DB; Ommen SR
J Thorac Cardiovasc Surg; 2023 Aug; 166(2):492-500.e2. PubMed ID: 34763894
[TBL] [Abstract][Full Text] [Related]
12. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
[TBL] [Abstract][Full Text] [Related]
13. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.
Qian D; Zhou X; Liu H; Cao L
J Clin Ultrasound; 2021 Jul; 49(6):554-562. PubMed ID: 33675543
[TBL] [Abstract][Full Text] [Related]
15. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.
Smedira NG; Lytle BW; Lever HM; Rajeswaran J; Krishnaswamy G; Kaple RK; Dolney DO; Blackstone EH
Ann Thorac Surg; 2008 Jan; 85(1):127-33. PubMed ID: 18154797
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
17. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
[TBL] [Abstract][Full Text] [Related]
18. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy.
Brown ML; Schaff HV; Dearani JA; Li Z; Nishimura RA; Ommen SR
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):439-43. PubMed ID: 20832083
[TBL] [Abstract][Full Text] [Related]
19. [Value of N-terminal pro-B-type natriuretic peptide on long-term outcome of patients with hypertrophic cardiomyopathy].
Meng XB; Wang WY; Zhang K; Qi Y; An SM; Wang SY; Zheng JL; Yu QJ; Tang B; Wu R; Wang SY; Gao CY; Tang YD
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):192-197. PubMed ID: 29562423
[No Abstract] [Full Text] [Related]
20. Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy.
ElBardissi AW; Dearani JA; Nishimura RA; Ommen SR; Stulak JM; Schaff HV
Mayo Clin Proc; 2007 Dec; 82(12):1516-22. PubMed ID: 18053460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
